Vortexa Unveils ‘Anywhere Freight Pricing’: The First Port-to-Port Freight Pricing Platform for Energy
20.2.2025 12:40:00 EET | Business Wire | Press release
Vortexa, a leading provider of global energy and freight market analytics, has launched Anywhere Freight Pricing—the world’s first port-to-port freight pricing platform for energy trading. This groundbreaking solution provides instant, unlimited pricing for over 50,000 active and 70 million possible Clean Petroleum Product (CPP) freight routes, setting an entirely new standard for speed and scale in the global freight markets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250220992839/en/
Fabio Kuhn, Founder and CEO of Vortexa (Photo: Business Wire)
The energy freight market has long struggled with highly inefficient pricing mechanisms and significant information asymmetries. Anywhere Freight Pricing empowers traders, charterers and shipowners with unparalleled access and transparency, redefining how freight trading decisions are made:
- Instant access: Any vessel class, origin and destination ports to get the latest freight rate for the specified route. Prices update daily, at 4:30PM UK time.
- Global coverage: 50,000+ active and 70+ million possible clean routes.
- Unlimited route comparison: Optimise pricing options by evaluating multiple routes, including breakdowns for port and canal fees.
- Historical data: 5 years of pricing data for all routes for seasonality and trend analysis, with optional vessel and cargo count overlay.
“Since the beginning of global energy markets, traders have strived for instant, unlimited access to sharp freight prices to evaluate their trading ideas before going firm on the market. With Anywhere Freight Pricing, Vortexa has made this a reality — forever transforming how energy freight is priced and traded”, said Fabio Kuhn, Founder and CEO of Vortexa.
Powered by Vortexa’s proprietary deep tech and market intelligence, this launch is set to transform trading in a market where freight is increasingly the key driver of profitability. The initial release focuses on clean products, with freight pricing for Dirty Petroleum Products (DPP) to follow in the coming months.
About Vortexa
Vortexa provides market-leading real-time data and analytics for energy and freight markets. Combining human intelligence with AI-driven insights, Vortexa helps its clients navigate the complex energy landscape with greater clarity and confidence. With a vision to build the future of energy markets, Vortexa empowers energy traders, analysts, and freight professionals to gain a competitive edge into complex and opaque markets by making trading decisions with confidence. Vortexa is a multidisciplinary force of over 170 employees combining the best of energy and freight expertise, data science and engineering in London, Geneva, Singapore, Houston, NYC and the UAE.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250220992839/en/
Contacts
Media contacts
Richard Kewish, VP of Strategic Projects & Partnerships
vafp@vortexa.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom